IMPROVING SURVIVAL IN METASTATIC CARCINOMA OF UNKNOWN ORIGIN

PREVIEWWhen the primary tumor site cannot be identified in patients with metastatic carcinoma, the survival rate is discouragingly low. In such cases, recognition of subgroups of patients who have a better chance of long-term survival is critical. In this article, Drs Brigden and Murray present a detailed approach to diagnosis and management.